Stocktoria

MAIA Biotechnology, Inc. MAIA

NYSE · stock · Pharmaceutical Preparations · website · IPO 2022-07-28

MAIA Biotechnology, Inc. statistics & valuation

Market cap$90.0M
P / B37.9×
Return on capital-627.4%

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20212022202320242025
Operating margin (%)
20212022202320242025
Return on equity (%)
-639.80% -942.70% 20212022202320242025
Shares outstanding
7.6M 11.0M 17.0M 26.2M 38.6M 20212022202320242025
Net debt ($)
20212022202320242025
Share buybacks ($)
20212022202320242025
Return on assets (%)
-229.00% -230.80% 20212022202320242025
Free cash flow margin (%)
20212022202320242025
Debt / equity (×)
20212022202320242025
EPS ($)
-$2.37 -$1.75 -$1.49 -$1.05 -$0.70 20212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021
Return on assets-230.8%-229.0%———
Return on equity-942.7%-639.8%———
Current ratio1.662.651.533.614.97

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.